Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Goldman Adds BHP Billiton To Conviction Buy List

Thu, 15th Jan 2015 09:49

LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
GOLDMAN SACHS RAISES BHP BILLITON TO 'CONVICTION BUY LIST' ('NEUTRAL') - PRICE TARGET 1575 (1870) PENCE
----------
NOMURA CUTS BG GROUP PRICE TARGET TO 900 (1000) PENCE - 'REDUCE'
----------
JEFFERIES CUTS BG GROUP PRICE TARGET TO 1215 (1250) PENCE - 'BUY'
----------
NOMURA CUTS BP PRICE TARGET TO 380 (430) PENCE - 'NEUTRAL'
----------
JEFFERIES CUTS BP PRICE TARGET TO 470 (490) PENCE - 'BUY'
----------
JEFFERIES CUTS SHELL A PRICE TARGET TO 2450 (2540) PENCE - 'BUY'
----------
NOMURA CUTS SHELL B PRICE TARGET TO 2350 (2600) PENCE - 'BUY'
----------
S&P CAPITAL IQ CUTS BHP BILLITON TO 'HOLD' ('BUY') - PRICE TARGET 1300 (1825) PENCE
----------
UBS CUTS BHP BILLITON PRICE TARGET TO 1870 (2000) PENCE - 'BUY'
----------
BARCLAYS CUTS BHP BILLITON PRICE TARGET TO 1500 (2100) PENCE - 'OVERWEIGHT'
----------
S&P CAPITAL IQ RAISES BURBERRY PRICE TARGET TO 1520 (1420) PENCE - 'SELL'
----------
TRADERS: NUMIS CUTS ANTOFAGASTA TO 'REDUCE' ('HOLD')
----------
S&P CAPITAL IQ CUTS ANTOFAGASTA TO 'SELL' ('HOLD') - TARGET 625 (760) PENCE
----------
BARCLAYS CUTS ANTOFAGASTA PRICE TARGET TO 700 (745) PENCE - 'EQUAL WEIGHT'
----------
S&P CAPITAL IQ CUTS RIO TINTO PRICE TARGET TO 2800 (3300) PENCE - 'HOLD'
----------
UBS CUTS RIO TINTO PRICE TARGET TO 3300 (3500) PENCE - 'BUY'
----------
BERNSTEIN RAISES RBS PRICE TARGET TO 470 (450) PENCE - 'OUTPERFORM'
----------
BARCLAYS CUTS ANGLO AMERICAN PRICE TARGET TO 1080 (1550) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES FRESNILLO PRICE TARGET TO 835 (800) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES RANDGOLD RESOURCES TARGET TO 5600 (4900) PENCE - 'OVERWEIGHT'
----------
TRADERS: NUMIS CUTS RANDGOLD RESOURCES TO 'HOLD' ('BUY')
----------
BARCLAYS RAISES COMPASS GROUP PRICE TARGET TO 1250 (1180) PENCE - 'OVERWEIGHT'
----------
CS CUTS COMPASS GROUP TO 'NEUTRAL' ('OUTPERFORM') - TARGET 190 PENCE
----------
BARCLAYS RAISES INTERCONTINENTAL HOTELS TARGET TO 2650 (2360) PENCE; 'EQUAL WEIGHT.'
----------
BARCLAYS RAISES WHITBREAD PRICE TARGET TO 5400 (4900) PENCE - 'OVERWEIGHT'
----------
Investec Raises BAT Price Target To 3,600P From 3,400P, Keeps At Hold
----------
EXANE BNP CUTS SKY PLC TO 'NEUTRAL' ('OUTPERFORM') - PRICE TARGET 1000 (985) PENCE
----------
EXANE BNP RAISES GKN PRICE TARGET TO 380 (340) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS SMITHS GROUP PRICE TARGET TO 1050 (1150) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS WEIR GROUP PRICE TARGET TO 1500 (1835) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 4800 (4350) PENCE - 'HOLD'
----------
DEUTSCHE BANK CUTS GLAXOSMITHKLINE PRICE TARGET TO 1300 (1390) PENCE - 'HOLD'
----------
HSBC RAISES EASYJET PRICE TARGET TO 1500 (1450) PENCE - 'UNDERWEIGHT'
----------
HSBC CUTS ADMIRAL GROUP PRICE TARGET TO 1590 (1625) PENCE - 'OVERWEIGHT'
----------
HSBC CUTS RSA INSURANCE PRICE TARGET TO 474 (480) PENCE - 'NEUTRAL'
----------
HSBC CUTS AVIVA PRICE TARGET TO 535 (590) PENCE - 'NEUTRAL'
----------
HSBC RAISES PRUDENTIAL PRICE TARGET TO 1800 (1725) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES DIRECT LINE PRICE TARGET TO 346 (335) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES FRIENDS LIFE PRICE TARGET TO 420 (415) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES LEGAL & GENERAL PRICE TARGET TO 296 (285) PENCE - 'OVERWEIGHT'
----------
HSBC CUTS STANDARD LIFE PRICE TARGET TO 425 (430) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
JPMORGAN RAISES REDEFINE INTERNATIONAL TARGET TO 53 (50) PENCE - 'UNDERWEIGHT'
----------
BERENBERG INITIATES BODYCOTE WITH 'HOLD' - TARGET 684 PENCE
----------
SOCGEN RAISES PROVIDENT FINANCIAL PRICE TARGET TO 2540 (2270) PENCE - 'HOLD'
----------
TRADERS: NUMIS CUTS KAZ MINERALS TO 'REDUCE' ('HOLD')
----------
BARCLAYS CUTS KAZ MINERALS PRICE TARGET TO 150 (255) PENCE - 'EQUAL WEIGHT'
----------
CREDIT SUISSE RAISES LADBROKES TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 115 PENCE
----------
BARCLAYS CUTS LADBROKES PRICE TARGET TO 104 (126) PENCE - 'EQUAL WEIGHT'
----------
CREDIT SUISSE CUTS DOMINO'S PIZZA TO 'NEUTRAL' ('OUTPERFORM') - TARGET 695 (650) PENCE
----------
TRADERS: CITIGROUP RAISES JUPITER FUND TO 'BUY' ('NEUTRAL')
----------
BARCLAYS CUTS LONMIN PRICE TARGET TO 155 (190) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS RAISES ACACIA MINING TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
BARCLAYS CUTS PETRA DIAMONDS PRICE TARGET TO 280 (290) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES POLYMETAL TO 'EQUAL WEIGHT' ('UNDERWEIGHT')
----------
BARCLAYS CUTS VEDANTA PRICE TARGET TO 400 (840) PENCE - 'UNDERWEIGHT'
----------
EXANE BNP RAISES TALK TALK TELECOM TARGET TO 220 (200) PENCE - 'UNDERPERFORM'
----------
BARCLAYS RAISES MERLIN ENTERTAINMENTS TARGET TO 450 (420) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS WILLIAM HILL PRICE TARGET TO 390 (400) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS MARSTONS TO 'UNDERWEIGHT' ('EQUAL WEIGHT') - TARGET 130 (150) PENCE
----------
EXANE BNP RAISES HALMA TO 'OUTPERFORM' ('NEUTRAL') - TARGET 780 (685) PENCE
----------
EXANE BNP RAISES ROTORK TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 2300 PENCE
----------
EXANE BNP CUTS SPECTRIS TO 'UNDERPERFORM' ('NEUTRAL') - TARGET 1825 (1740) PENCE
----------
EXANE BNP RAISES SPIRAX-SARCO TO 'NEUTRAL' ('UNDERPERFORM')
----------
EXANE BNP RAISES SPIRAX-SARCO TARGET TO 2935 (2450) PENCE
----------
EXANE BNP RAISES VESUVIUS TO 'OUTPERFORM' ('NEUTRAL') - TARGET 510 (440) PENCE
----------
BARCLAYS RAISES BETFAIR PRICE TARGET TO 1626 (1576) PENCE - 'OVERWEIGHT'
----------
SOCGEN RAISES BBA AVIATION PRICE TARGET TO 400 (360) PENCE - 'BUY'
----------
HSBC CUTS CATLIN GROUP TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 720 (620) PENCE
----------
HSBC CUTS PHOENIX GROUP TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 875 (870) PENCE
----------
HSBC RAISES AMLIN PRICE TARGET TO 433 (420) PENCE - 'UNDERWEIGHT'
----------
HSBC RAISES ESURE GROUP PRICE TARGET TO 330 (320) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES HISCOX PRICE TARGET TO 715 (690) PENCE - 'NEUTRAL'
----------
HSBC RAISES LANCASHIRE HLDGS PRICE TARGET TO 655 (650) PENCE - 'OVERWEIGHT'
----------
MAIN MARKET AND AIM
----------
UBS CUTS FENNER PRICE TARGET TO 210 (235) PENCE - 'NEUTRAL'
----------
UBS CUTS PREMIER OIL PRICE TARGET TO 200 (300) PENCE - 'BUY'
----------
TRADERS: NUMIS CUTS PETROPAVLOVSK TO 'SELL' ('REDUCE')
----------
BARCLAYS CUTS FERREXPO TO 'UNDERWEIGHT' ('EQUAL WEIGHT.') - TARGET 50 (140) PENCE
----------
BARCLAYS CUTS GEM DIAMONDS PRICE TARGET TO 245 (260) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES HOCHSCHILD MINING TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
PANMURE RAISES SQS SOFTWARE PRICE TARGET TO 590 (527) PENCE - 'HOLD'
----------
HSBC RAISES FLYBE GROUP PRICE TARGET TO 150 (140) PENCE - 'OVERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.